Articles published by Ultragenyx Pharmaceutical Inc.
Via GlobeNewswire
Tickers
RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 20, 2023
Via GlobeNewswire
Tickers
RARE
Ultragenyx to Participate at Investor Conferences in September
August 31, 2023
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Ultragenyx to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
June 07, 2023
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President
March 14, 2023
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Ultragenyx Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
February 16, 2023
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.